nodes	percent_of_prediction	percent_of_DWPC	metapath
Maprotiline—HTR2A—Alzheimer's disease	0.17	0.522	CbGaD
Maprotiline—CYP2D6—Alzheimer's disease	0.156	0.478	CbGaD
Maprotiline—HTR2A—Donepezil—Alzheimer's disease	0.127	0.362	CbGbCtD
Maprotiline—DRD2—Memantine—Alzheimer's disease	0.101	0.289	CbGbCtD
Maprotiline—CYP2D6—Rivastigmine—Alzheimer's disease	0.0527	0.151	CbGbCtD
Maprotiline—CYP2D6—Donepezil—Alzheimer's disease	0.0422	0.12	CbGbCtD
Maprotiline—CYP2D6—Galantamine—Alzheimer's disease	0.0272	0.0776	CbGbCtD
Maprotiline—HTR2C—choroid plexus—Alzheimer's disease	0.0103	0.132	CbGeAlD
Maprotiline—SLC6A2—locus ceruleus—Alzheimer's disease	0.00529	0.0679	CbGeAlD
Maprotiline—HTR2A—choroid plexus—Alzheimer's disease	0.00515	0.066	CbGeAlD
Maprotiline—HTR7—locus ceruleus—Alzheimer's disease	0.0051	0.0654	CbGeAlD
Maprotiline—HTR2A—locus ceruleus—Alzheimer's disease	0.00318	0.0408	CbGeAlD
Maprotiline—SLC6A3—telencephalic ventricle—Alzheimer's disease	0.00311	0.0399	CbGeAlD
Maprotiline—HTR2C—telencephalic ventricle—Alzheimer's disease	0.00301	0.0386	CbGeAlD
Maprotiline—HTR2A—cerebellar cortex—Alzheimer's disease	0.00259	0.0332	CbGeAlD
Maprotiline—HTR7—telencephalic ventricle—Alzheimer's disease	0.00242	0.031	CbGeAlD
Maprotiline—DRD2—telencephalic ventricle—Alzheimer's disease	0.00229	0.0293	CbGeAlD
Maprotiline—HTR2A—telencephalic ventricle—Alzheimer's disease	0.00151	0.0193	CbGeAlD
Maprotiline—HTR7—blood vessel—Alzheimer's disease	0.0012	0.0153	CbGeAlD
Maprotiline—Sertraline—MAOB—Alzheimer's disease	0.00111	0.217	CrCbGaD
Maprotiline—CHRM4—nervous system—Alzheimer's disease	0.000824	0.0106	CbGeAlD
Maprotiline—CHRM2—forebrain—Alzheimer's disease	0.000815	0.0104	CbGeAlD
Maprotiline—SLC6A3—forebrain—Alzheimer's disease	0.000812	0.0104	CbGeAlD
Maprotiline—CHRM4—central nervous system—Alzheimer's disease	0.000794	0.0102	CbGeAlD
Maprotiline—HTR2C—forebrain—Alzheimer's disease	0.000785	0.0101	CbGeAlD
Maprotiline—CHRM2—telencephalon—Alzheimer's disease	0.000749	0.0096	CbGeAlD
Maprotiline—SLC6A3—telencephalon—Alzheimer's disease	0.000747	0.00958	CbGeAlD
Maprotiline—HTR2A—blood vessel—Alzheimer's disease	0.000747	0.00957	CbGeAlD
Maprotiline—CHRM1—forebrain—Alzheimer's disease	0.000741	0.00951	CbGeAlD
Maprotiline—HTR2C—telencephalon—Alzheimer's disease	0.000722	0.00926	CbGeAlD
Maprotiline—Dimetacrine—ACHE—Alzheimer's disease	0.000721	0.141	CrCbGaD
Maprotiline—CHRM1—telencephalon—Alzheimer's disease	0.000682	0.00874	CbGeAlD
Maprotiline—CHRM3—forebrain—Alzheimer's disease	0.000664	0.00851	CbGeAlD
Maprotiline—SLC6A2—forebrain—Alzheimer's disease	0.000655	0.0084	CbGeAlD
Maprotiline—CHRM5—nervous system—Alzheimer's disease	0.000644	0.00826	CbGeAlD
Maprotiline—HTR7—forebrain—Alzheimer's disease	0.000632	0.0081	CbGeAlD
Maprotiline—CHRM4—brain—Alzheimer's disease	0.00063	0.00808	CbGeAlD
Maprotiline—CHRM5—central nervous system—Alzheimer's disease	0.00062	0.00795	CbGeAlD
Maprotiline—CHRM3—telencephalon—Alzheimer's disease	0.00061	0.00782	CbGeAlD
Maprotiline—SLC6A2—telencephalon—Alzheimer's disease	0.000603	0.00773	CbGeAlD
Maprotiline—DRD2—forebrain—Alzheimer's disease	0.000597	0.00766	CbGeAlD
Maprotiline—HTR7—telencephalon—Alzheimer's disease	0.000581	0.00745	CbGeAlD
Maprotiline—DRD2—telencephalon—Alzheimer's disease	0.000549	0.00704	CbGeAlD
Maprotiline—Sertraline—SLC6A4—Alzheimer's disease	0.000503	0.0982	CrCbGaD
Maprotiline—CHRM5—brain—Alzheimer's disease	0.000492	0.00631	CbGeAlD
Maprotiline—ABCB1—blood vessel—Alzheimer's disease	0.000489	0.00627	CbGeAlD
Maprotiline—ORM1—nervous system—Alzheimer's disease	0.000474	0.00608	CbGeAlD
Maprotiline—HRH1—forebrain—Alzheimer's disease	0.000472	0.00605	CbGeAlD
Maprotiline—ORM1—central nervous system—Alzheimer's disease	0.000457	0.00585	CbGeAlD
Maprotiline—HTR2A—embryo—Alzheimer's disease	0.000445	0.00571	CbGeAlD
Maprotiline—CHRM2—nervous system—Alzheimer's disease	0.000442	0.00567	CbGeAlD
Maprotiline—SLC6A3—nervous system—Alzheimer's disease	0.000441	0.00565	CbGeAlD
Maprotiline—HRH1—telencephalon—Alzheimer's disease	0.000434	0.00556	CbGeAlD
Maprotiline—Muscular weakness—Rivastigmine—Alzheimer's disease	0.000427	0.00253	CcSEcCtD
Maprotiline—HTR2C—nervous system—Alzheimer's disease	0.000426	0.00547	CbGeAlD
Maprotiline—CHRM2—central nervous system—Alzheimer's disease	0.000426	0.00546	CbGeAlD
Maprotiline—Weight decreased—Donepezil—Alzheimer's disease	0.000426	0.00253	CcSEcCtD
Maprotiline—SLC6A3—central nervous system—Alzheimer's disease	0.000425	0.00544	CbGeAlD
Maprotiline—Malnutrition—Galantamine—Alzheimer's disease	0.000423	0.00251	CcSEcCtD
Maprotiline—Bronchospasm—Memantine—Alzheimer's disease	0.00042	0.00249	CcSEcCtD
Maprotiline—Infestation—Donepezil—Alzheimer's disease	0.00042	0.00249	CcSEcCtD
Maprotiline—Infestation NOS—Donepezil—Alzheimer's disease	0.00042	0.00249	CcSEcCtD
Maprotiline—Dysphagia—Rivastigmine—Alzheimer's disease	0.000418	0.00248	CcSEcCtD
Maprotiline—Sweating increased—Memantine—Alzheimer's disease	0.000416	0.00247	CcSEcCtD
Maprotiline—Tension—Galantamine—Alzheimer's disease	0.000415	0.00246	CcSEcCtD
Maprotiline—SLC6A3—cerebellum—Alzheimer's disease	0.000415	0.00532	CbGeAlD
Maprotiline—Dysgeusia—Galantamine—Alzheimer's disease	0.000414	0.00246	CcSEcCtD
Maprotiline—Acute coronary syndrome—Donepezil—Alzheimer's disease	0.000414	0.00245	CcSEcCtD
Maprotiline—Myocardial infarction—Donepezil—Alzheimer's disease	0.000411	0.00244	CcSEcCtD
Maprotiline—Bronchospasm—Rivastigmine—Alzheimer's disease	0.000411	0.00244	CcSEcCtD
Maprotiline—Nervousness—Galantamine—Alzheimer's disease	0.000411	0.00244	CcSEcCtD
Maprotiline—HTR2C—central nervous system—Alzheimer's disease	0.00041	0.00526	CbGeAlD
Maprotiline—Jaundice—Donepezil—Alzheimer's disease	0.000409	0.00243	CcSEcCtD
Maprotiline—Sweating increased—Rivastigmine—Alzheimer's disease	0.000407	0.00241	CcSEcCtD
Maprotiline—Pancytopenia—Memantine—Alzheimer's disease	0.000406	0.00241	CcSEcCtD
Maprotiline—CHRM1—nervous system—Alzheimer's disease	0.000403	0.00516	CbGeAlD
Maprotiline—Vision blurred—Galantamine—Alzheimer's disease	0.000399	0.00236	CcSEcCtD
Maprotiline—Tremor—Galantamine—Alzheimer's disease	0.000396	0.00235	CcSEcCtD
Maprotiline—Pollakiuria—Memantine—Alzheimer's disease	0.000395	0.00234	CcSEcCtD
Maprotiline—HTR2A—forebrain—Alzheimer's disease	0.000394	0.00505	CbGeAlD
Maprotiline—Erectile dysfunction—Memantine—Alzheimer's disease	0.000393	0.00233	CcSEcCtD
Maprotiline—Weight increased—Memantine—Alzheimer's disease	0.000389	0.00231	CcSEcCtD
Maprotiline—Agitation—Galantamine—Alzheimer's disease	0.000389	0.00231	CcSEcCtD
Maprotiline—CHRM1—central nervous system—Alzheimer's disease	0.000388	0.00497	CbGeAlD
Maprotiline—Weight decreased—Memantine—Alzheimer's disease	0.000387	0.00229	CcSEcCtD
Maprotiline—Pollakiuria—Rivastigmine—Alzheimer's disease	0.000386	0.00229	CcSEcCtD
Maprotiline—Erectile dysfunction—Rivastigmine—Alzheimer's disease	0.000385	0.00228	CcSEcCtD
Maprotiline—Photosensitivity reaction—Rivastigmine—Alzheimer's disease	0.000382	0.00226	CcSEcCtD
Maprotiline—Infestation NOS—Memantine—Alzheimer's disease	0.000381	0.00226	CcSEcCtD
Maprotiline—Infestation—Memantine—Alzheimer's disease	0.000381	0.00226	CcSEcCtD
Maprotiline—Weight increased—Rivastigmine—Alzheimer's disease	0.00038	0.00226	CcSEcCtD
Maprotiline—Syncope—Galantamine—Alzheimer's disease	0.000379	0.00225	CcSEcCtD
Maprotiline—Weight decreased—Rivastigmine—Alzheimer's disease	0.000378	0.00224	CcSEcCtD
Maprotiline—Stevens-Johnson syndrome—Memantine—Alzheimer's disease	0.000378	0.00224	CcSEcCtD
Maprotiline—Hepatitis—Donepezil—Alzheimer's disease	0.000377	0.00223	CcSEcCtD
Maprotiline—Acute coronary syndrome—Memantine—Alzheimer's disease	0.000376	0.00223	CcSEcCtD
Maprotiline—Hallucination—Donepezil—Alzheimer's disease	0.000375	0.00222	CcSEcCtD
Maprotiline—Hypoaesthesia—Donepezil—Alzheimer's disease	0.000375	0.00222	CcSEcCtD
Maprotiline—Palpitations—Galantamine—Alzheimer's disease	0.000374	0.00222	CcSEcCtD
Maprotiline—Neuropathy peripheral—Memantine—Alzheimer's disease	0.000373	0.00221	CcSEcCtD
Maprotiline—Myocardial infarction—Memantine—Alzheimer's disease	0.000373	0.00221	CcSEcCtD
Maprotiline—Drowsiness—Rivastigmine—Alzheimer's disease	0.000373	0.00221	CcSEcCtD
Maprotiline—Infestation—Rivastigmine—Alzheimer's disease	0.000373	0.00221	CcSEcCtD
Maprotiline—Infestation NOS—Rivastigmine—Alzheimer's disease	0.000373	0.00221	CcSEcCtD
Maprotiline—Urinary tract disorder—Donepezil—Alzheimer's disease	0.000372	0.00221	CcSEcCtD
Maprotiline—Loss of consciousness—Galantamine—Alzheimer's disease	0.000372	0.00221	CcSEcCtD
Maprotiline—Stevens-Johnson syndrome—Rivastigmine—Alzheimer's disease	0.000369	0.00219	CcSEcCtD
Maprotiline—Urethral disorder—Donepezil—Alzheimer's disease	0.000369	0.00219	CcSEcCtD
Maprotiline—Acute coronary syndrome—Rivastigmine—Alzheimer's disease	0.000367	0.00218	CcSEcCtD
Maprotiline—Convulsion—Galantamine—Alzheimer's disease	0.000367	0.00217	CcSEcCtD
Maprotiline—Myocardial infarction—Rivastigmine—Alzheimer's disease	0.000365	0.00217	CcSEcCtD
Maprotiline—Neuropathy peripheral—Rivastigmine—Alzheimer's disease	0.000365	0.00217	CcSEcCtD
Maprotiline—Hypertension—Galantamine—Alzheimer's disease	0.000365	0.00217	CcSEcCtD
Maprotiline—HTR2A—telencephalon—Alzheimer's disease	0.000362	0.00464	CbGeAlD
Maprotiline—Hepatobiliary disease—Memantine—Alzheimer's disease	0.00036	0.00214	CcSEcCtD
Maprotiline—CHRM3—nervous system—Alzheimer's disease	0.00036	0.00462	CbGeAlD
Maprotiline—Anxiety—Galantamine—Alzheimer's disease	0.000359	0.00213	CcSEcCtD
Maprotiline—CYP2D6—forebrain—Alzheimer's disease	0.000359	0.0046	CbGeAlD
Maprotiline—Unspecified disorder of skin and subcutaneous tissue—Galantamine—Alzheimer's disease	0.000358	0.00212	CcSEcCtD
Maprotiline—SLC6A2—nervous system—Alzheimer's disease	0.000356	0.00456	CbGeAlD
Maprotiline—Agranulocytosis—Memantine—Alzheimer's disease	0.000355	0.00211	CcSEcCtD
Maprotiline—Sertraline—CYP2D6—Alzheimer's disease	0.000353	0.069	CrCbGaD
Maprotiline—Hepatobiliary disease—Rivastigmine—Alzheimer's disease	0.000352	0.00209	CcSEcCtD
Maprotiline—Dry mouth—Galantamine—Alzheimer's disease	0.000352	0.00209	CcSEcCtD
Maprotiline—Tinnitus—Donepezil—Alzheimer's disease	0.000351	0.00208	CcSEcCtD
Maprotiline—Confusional state—Galantamine—Alzheimer's disease	0.000348	0.00206	CcSEcCtD
Maprotiline—CHRM3—central nervous system—Alzheimer's disease	0.000347	0.00445	CbGeAlD
Maprotiline—HTR7—nervous system—Alzheimer's disease	0.000343	0.0044	CbGeAlD
Maprotiline—SLC6A2—central nervous system—Alzheimer's disease	0.000343	0.00439	CbGeAlD
Maprotiline—Hepatitis—Memantine—Alzheimer's disease	0.000342	0.00203	CcSEcCtD
Maprotiline—Hallucination—Memantine—Alzheimer's disease	0.00034	0.00202	CcSEcCtD
Maprotiline—Hypoaesthesia—Memantine—Alzheimer's disease	0.00034	0.00202	CcSEcCtD
Maprotiline—Shock—Galantamine—Alzheimer's disease	0.00034	0.00201	CcSEcCtD
Maprotiline—Nervous system disorder—Galantamine—Alzheimer's disease	0.000339	0.00201	CcSEcCtD
Maprotiline—Thrombocytopenia—Galantamine—Alzheimer's disease	0.000338	0.00201	CcSEcCtD
Maprotiline—CHRM2—brain—Alzheimer's disease	0.000338	0.00433	CbGeAlD
Maprotiline—Urinary tract disorder—Memantine—Alzheimer's disease	0.000338	0.002	CcSEcCtD
Maprotiline—SLC6A3—brain—Alzheimer's disease	0.000337	0.00432	CbGeAlD
Maprotiline—Tachycardia—Galantamine—Alzheimer's disease	0.000337	0.002	CcSEcCtD
Maprotiline—Arrhythmia—Donepezil—Alzheimer's disease	0.000336	0.002	CcSEcCtD
Maprotiline—Skin disorder—Galantamine—Alzheimer's disease	0.000335	0.00199	CcSEcCtD
Maprotiline—Urethral disorder—Memantine—Alzheimer's disease	0.000335	0.00199	CcSEcCtD
Maprotiline—Hepatitis—Rivastigmine—Alzheimer's disease	0.000335	0.00198	CcSEcCtD
Maprotiline—Hyperhidrosis—Galantamine—Alzheimer's disease	0.000334	0.00198	CcSEcCtD
Maprotiline—Hypoaesthesia—Rivastigmine—Alzheimer's disease	0.000333	0.00197	CcSEcCtD
Maprotiline—Hallucination—Rivastigmine—Alzheimer's disease	0.000333	0.00197	CcSEcCtD
Maprotiline—Alopecia—Donepezil—Alzheimer's disease	0.000333	0.00197	CcSEcCtD
Maprotiline—Atomoxetine—HTR6—Alzheimer's disease	0.000331	0.0647	CrCbGaD
Maprotiline—Urinary tract disorder—Rivastigmine—Alzheimer's disease	0.00033	0.00196	CcSEcCtD
Maprotiline—HTR7—central nervous system—Alzheimer's disease	0.00033	0.00423	CbGeAlD
Maprotiline—CYP2D6—telencephalon—Alzheimer's disease	0.00033	0.00423	CbGeAlD
Maprotiline—Urethral disorder—Rivastigmine—Alzheimer's disease	0.000328	0.00195	CcSEcCtD
Maprotiline—Malnutrition—Donepezil—Alzheimer's disease	0.000328	0.00194	CcSEcCtD
Maprotiline—HTR2C—brain—Alzheimer's disease	0.000326	0.00418	CbGeAlD
Maprotiline—DRD2—nervous system—Alzheimer's disease	0.000324	0.00416	CbGeAlD
Maprotiline—Erythema multiforme—Memantine—Alzheimer's disease	0.000323	0.00192	CcSEcCtD
Maprotiline—HTR7—cerebellum—Alzheimer's disease	0.000323	0.00414	CbGeAlD
Maprotiline—Hypotension—Galantamine—Alzheimer's disease	0.000323	0.00191	CcSEcCtD
Maprotiline—Tension—Donepezil—Alzheimer's disease	0.000322	0.00191	CcSEcCtD
Maprotiline—Dysgeusia—Donepezil—Alzheimer's disease	0.000321	0.0019	CcSEcCtD
Maprotiline—Eye disorder—Memantine—Alzheimer's disease	0.00032	0.0019	CcSEcCtD
Maprotiline—Tinnitus—Memantine—Alzheimer's disease	0.000319	0.00189	CcSEcCtD
Maprotiline—Nervousness—Donepezil—Alzheimer's disease	0.000318	0.00189	CcSEcCtD
Maprotiline—Flushing—Memantine—Alzheimer's disease	0.000317	0.00188	CcSEcCtD
Maprotiline—Cardiac disorder—Memantine—Alzheimer's disease	0.000317	0.00188	CcSEcCtD
Maprotiline—Erythema multiforme—Rivastigmine—Alzheimer's disease	0.000316	0.00188	CcSEcCtD
Maprotiline—Eye disorder—Rivastigmine—Alzheimer's disease	0.000313	0.00185	CcSEcCtD
Maprotiline—Insomnia—Galantamine—Alzheimer's disease	0.000312	0.00185	CcSEcCtD
Maprotiline—DRD2—central nervous system—Alzheimer's disease	0.000312	0.004	CbGeAlD
Maprotiline—Tinnitus—Rivastigmine—Alzheimer's disease	0.000312	0.00185	CcSEcCtD
Maprotiline—Flushing—Rivastigmine—Alzheimer's disease	0.00031	0.00184	CcSEcCtD
Maprotiline—Cardiac disorder—Rivastigmine—Alzheimer's disease	0.00031	0.00184	CcSEcCtD
Maprotiline—Angiopathy—Memantine—Alzheimer's disease	0.00031	0.00184	CcSEcCtD
Maprotiline—Paraesthesia—Galantamine—Alzheimer's disease	0.00031	0.00184	CcSEcCtD
Maprotiline—Vision blurred—Donepezil—Alzheimer's disease	0.000309	0.00183	CcSEcCtD
Maprotiline—Mediastinal disorder—Memantine—Alzheimer's disease	0.000308	0.00183	CcSEcCtD
Maprotiline—CHRM1—brain—Alzheimer's disease	0.000308	0.00394	CbGeAlD
Maprotiline—Tremor—Donepezil—Alzheimer's disease	0.000307	0.00182	CcSEcCtD
Maprotiline—Somnolence—Galantamine—Alzheimer's disease	0.000307	0.00182	CcSEcCtD
Maprotiline—Arrhythmia—Memantine—Alzheimer's disease	0.000305	0.00181	CcSEcCtD
Maprotiline—DRD2—cerebellum—Alzheimer's disease	0.000305	0.00391	CbGeAlD
Maprotiline—Dyspepsia—Galantamine—Alzheimer's disease	0.000304	0.0018	CcSEcCtD
Maprotiline—Angiopathy—Rivastigmine—Alzheimer's disease	0.000304	0.0018	CcSEcCtD
Maprotiline—Alopecia—Memantine—Alzheimer's disease	0.000302	0.00179	CcSEcCtD
Maprotiline—Mediastinal disorder—Rivastigmine—Alzheimer's disease	0.000302	0.00179	CcSEcCtD
Maprotiline—Agitation—Donepezil—Alzheimer's disease	0.000301	0.00179	CcSEcCtD
Maprotiline—Arrhythmia—Rivastigmine—Alzheimer's disease	0.000299	0.00177	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Galantamine—Alzheimer's disease	0.000298	0.00177	CcSEcCtD
Maprotiline—Malnutrition—Memantine—Alzheimer's disease	0.000298	0.00177	CcSEcCtD
Maprotiline—Fatigue—Galantamine—Alzheimer's disease	0.000298	0.00177	CcSEcCtD
Maprotiline—Alopecia—Rivastigmine—Alzheimer's disease	0.000296	0.00175	CcSEcCtD
Maprotiline—Constipation—Galantamine—Alzheimer's disease	0.000295	0.00175	CcSEcCtD
Maprotiline—Syncope—Donepezil—Alzheimer's disease	0.000294	0.00174	CcSEcCtD
Maprotiline—Tension—Memantine—Alzheimer's disease	0.000292	0.00173	CcSEcCtD
Maprotiline—ABCB1—embryo—Alzheimer's disease	0.000292	0.00374	CbGeAlD
Maprotiline—Dysgeusia—Memantine—Alzheimer's disease	0.000292	0.00173	CcSEcCtD
Maprotiline—Malnutrition—Rivastigmine—Alzheimer's disease	0.000291	0.00173	CcSEcCtD
Maprotiline—Nortriptyline—HTR6—Alzheimer's disease	0.000289	0.0565	CrCbGaD
Maprotiline—Nervousness—Memantine—Alzheimer's disease	0.000289	0.00171	CcSEcCtD
Maprotiline—Protriptyline—SLC6A4—Alzheimer's disease	0.000289	0.0564	CrCbGaD
Maprotiline—Loss of consciousness—Donepezil—Alzheimer's disease	0.000288	0.00171	CcSEcCtD
Maprotiline—Tension—Rivastigmine—Alzheimer's disease	0.000286	0.0017	CcSEcCtD
Maprotiline—Dysgeusia—Rivastigmine—Alzheimer's disease	0.000285	0.00169	CcSEcCtD
Maprotiline—Feeling abnormal—Galantamine—Alzheimer's disease	0.000285	0.00169	CcSEcCtD
Maprotiline—Convulsion—Donepezil—Alzheimer's disease	0.000284	0.00168	CcSEcCtD
Maprotiline—Hypertension—Donepezil—Alzheimer's disease	0.000283	0.00168	CcSEcCtD
Maprotiline—Nervousness—Rivastigmine—Alzheimer's disease	0.000283	0.00168	CcSEcCtD
Maprotiline—Gastrointestinal pain—Galantamine—Alzheimer's disease	0.000282	0.00167	CcSEcCtD
Maprotiline—Vision blurred—Memantine—Alzheimer's disease	0.000281	0.00166	CcSEcCtD
Maprotiline—Tremor—Memantine—Alzheimer's disease	0.000279	0.00165	CcSEcCtD
Maprotiline—Anxiety—Donepezil—Alzheimer's disease	0.000278	0.00165	CcSEcCtD
Maprotiline—CHRM3—brain—Alzheimer's disease	0.000275	0.00353	CbGeAlD
Maprotiline—Vision blurred—Rivastigmine—Alzheimer's disease	0.000274	0.00163	CcSEcCtD
Maprotiline—Agitation—Memantine—Alzheimer's disease	0.000274	0.00162	CcSEcCtD
Maprotiline—Dry mouth—Donepezil—Alzheimer's disease	0.000273	0.00162	CcSEcCtD
Maprotiline—Abdominal pain—Galantamine—Alzheimer's disease	0.000273	0.00162	CcSEcCtD
Maprotiline—Body temperature increased—Galantamine—Alzheimer's disease	0.000273	0.00162	CcSEcCtD
Maprotiline—Tremor—Rivastigmine—Alzheimer's disease	0.000273	0.00162	CcSEcCtD
Maprotiline—SLC6A2—brain—Alzheimer's disease	0.000272	0.00349	CbGeAlD
Maprotiline—Confusional state—Donepezil—Alzheimer's disease	0.00027	0.0016	CcSEcCtD
Maprotiline—Agitation—Rivastigmine—Alzheimer's disease	0.000268	0.00159	CcSEcCtD
Maprotiline—Oedema—Donepezil—Alzheimer's disease	0.000268	0.00159	CcSEcCtD
Maprotiline—Syncope—Memantine—Alzheimer's disease	0.000267	0.00158	CcSEcCtD
Maprotiline—Leukopenia—Memantine—Alzheimer's disease	0.000266	0.00158	CcSEcCtD
Maprotiline—Infection—Donepezil—Alzheimer's disease	0.000266	0.00158	CcSEcCtD
Maprotiline—Shock—Donepezil—Alzheimer's disease	0.000263	0.00156	CcSEcCtD
Maprotiline—Palpitations—Memantine—Alzheimer's disease	0.000263	0.00156	CcSEcCtD
Maprotiline—Nervous system disorder—Donepezil—Alzheimer's disease	0.000262	0.00156	CcSEcCtD
Maprotiline—HTR7—brain—Alzheimer's disease	0.000262	0.00336	CbGeAlD
Maprotiline—Thrombocytopenia—Donepezil—Alzheimer's disease	0.000262	0.00155	CcSEcCtD
Maprotiline—Loss of consciousness—Memantine—Alzheimer's disease	0.000262	0.00155	CcSEcCtD
Maprotiline—Syncope—Rivastigmine—Alzheimer's disease	0.000261	0.00155	CcSEcCtD
Maprotiline—Hyperhidrosis—Donepezil—Alzheimer's disease	0.000259	0.00153	CcSEcCtD
Maprotiline—ABCB1—forebrain—Alzheimer's disease	0.000258	0.00331	CbGeAlD
Maprotiline—Convulsion—Memantine—Alzheimer's disease	0.000258	0.00153	CcSEcCtD
Maprotiline—Palpitations—Rivastigmine—Alzheimer's disease	0.000257	0.00153	CcSEcCtD
Maprotiline—Hypertension—Memantine—Alzheimer's disease	0.000257	0.00152	CcSEcCtD
Maprotiline—HRH1—nervous system—Alzheimer's disease	0.000256	0.00328	CbGeAlD
Maprotiline—Loss of consciousness—Rivastigmine—Alzheimer's disease	0.000256	0.00152	CcSEcCtD
Maprotiline—Anxiety—Memantine—Alzheimer's disease	0.000253	0.0015	CcSEcCtD
Maprotiline—Convulsion—Rivastigmine—Alzheimer's disease	0.000252	0.0015	CcSEcCtD
Maprotiline—Hypertension—Rivastigmine—Alzheimer's disease	0.000251	0.00149	CcSEcCtD
Maprotiline—Hypotension—Donepezil—Alzheimer's disease	0.00025	0.00148	CcSEcCtD
Maprotiline—Dry mouth—Memantine—Alzheimer's disease	0.000248	0.00147	CcSEcCtD
Maprotiline—DRD2—brain—Alzheimer's disease	0.000248	0.00318	CbGeAlD
Maprotiline—Asthenia—Galantamine—Alzheimer's disease	0.000248	0.00147	CcSEcCtD
Maprotiline—Anxiety—Rivastigmine—Alzheimer's disease	0.000247	0.00147	CcSEcCtD
Maprotiline—HRH1—central nervous system—Alzheimer's disease	0.000246	0.00316	CbGeAlD
Maprotiline—Unspecified disorder of skin and subcutaneous tissue—Rivastigmine—Alzheimer's disease	0.000246	0.00146	CcSEcCtD
Maprotiline—Confusional state—Memantine—Alzheimer's disease	0.000245	0.00145	CcSEcCtD
Maprotiline—Oedema—Memantine—Alzheimer's disease	0.000243	0.00144	CcSEcCtD
Maprotiline—Dry mouth—Rivastigmine—Alzheimer's disease	0.000242	0.00144	CcSEcCtD
Maprotiline—Insomnia—Donepezil—Alzheimer's disease	0.000242	0.00144	CcSEcCtD
Maprotiline—Infection—Memantine—Alzheimer's disease	0.000241	0.00143	CcSEcCtD
Maprotiline—Paraesthesia—Donepezil—Alzheimer's disease	0.00024	0.00143	CcSEcCtD
Maprotiline—Confusional state—Rivastigmine—Alzheimer's disease	0.00024	0.00142	CcSEcCtD
Maprotiline—Shock—Memantine—Alzheimer's disease	0.000239	0.00142	CcSEcCtD
Maprotiline—Nervous system disorder—Memantine—Alzheimer's disease	0.000238	0.00141	CcSEcCtD
Maprotiline—Somnolence—Donepezil—Alzheimer's disease	0.000238	0.00141	CcSEcCtD
Maprotiline—Thrombocytopenia—Memantine—Alzheimer's disease	0.000238	0.00141	CcSEcCtD
Maprotiline—Oedema—Rivastigmine—Alzheimer's disease	0.000238	0.00141	CcSEcCtD
Maprotiline—ABCB1—telencephalon—Alzheimer's disease	0.000237	0.00304	CbGeAlD
Maprotiline—Tachycardia—Memantine—Alzheimer's disease	0.000237	0.00141	CcSEcCtD
Maprotiline—Diarrhoea—Galantamine—Alzheimer's disease	0.000236	0.0014	CcSEcCtD
Maprotiline—Infection—Rivastigmine—Alzheimer's disease	0.000236	0.0014	CcSEcCtD
Maprotiline—Skin disorder—Memantine—Alzheimer's disease	0.000236	0.0014	CcSEcCtD
Maprotiline—Dyspepsia—Donepezil—Alzheimer's disease	0.000236	0.0014	CcSEcCtD
Maprotiline—Hyperhidrosis—Memantine—Alzheimer's disease	0.000235	0.00139	CcSEcCtD
Maprotiline—Shock—Rivastigmine—Alzheimer's disease	0.000234	0.00139	CcSEcCtD
Maprotiline—Nervous system disorder—Rivastigmine—Alzheimer's disease	0.000233	0.00138	CcSEcCtD
Maprotiline—Thrombocytopenia—Rivastigmine—Alzheimer's disease	0.000233	0.00138	CcSEcCtD
Maprotiline—Tachycardia—Rivastigmine—Alzheimer's disease	0.000232	0.00138	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Donepezil—Alzheimer's disease	0.000231	0.00137	CcSEcCtD
Maprotiline—Skin disorder—Rivastigmine—Alzheimer's disease	0.000231	0.00137	CcSEcCtD
Maprotiline—Fatigue—Donepezil—Alzheimer's disease	0.000231	0.00137	CcSEcCtD
Maprotiline—Hyperhidrosis—Rivastigmine—Alzheimer's disease	0.00023	0.00136	CcSEcCtD
Maprotiline—Constipation—Donepezil—Alzheimer's disease	0.000229	0.00136	CcSEcCtD
Maprotiline—Dizziness—Galantamine—Alzheimer's disease	0.000228	0.00135	CcSEcCtD
Maprotiline—Hypotension—Memantine—Alzheimer's disease	0.000227	0.00135	CcSEcCtD
Maprotiline—Hypotension—Rivastigmine—Alzheimer's disease	0.000222	0.00132	CcSEcCtD
Maprotiline—Feeling abnormal—Donepezil—Alzheimer's disease	0.000221	0.00131	CcSEcCtD
Maprotiline—Insomnia—Memantine—Alzheimer's disease	0.00022	0.0013	CcSEcCtD
Maprotiline—Vomiting—Galantamine—Alzheimer's disease	0.00022	0.0013	CcSEcCtD
Maprotiline—Gastrointestinal pain—Donepezil—Alzheimer's disease	0.000219	0.0013	CcSEcCtD
Maprotiline—Paraesthesia—Memantine—Alzheimer's disease	0.000218	0.00129	CcSEcCtD
Maprotiline—Rash—Galantamine—Alzheimer's disease	0.000218	0.00129	CcSEcCtD
Maprotiline—Dermatitis—Galantamine—Alzheimer's disease	0.000218	0.00129	CcSEcCtD
Maprotiline—Headache—Galantamine—Alzheimer's disease	0.000216	0.00128	CcSEcCtD
Maprotiline—Somnolence—Memantine—Alzheimer's disease	0.000216	0.00128	CcSEcCtD
Maprotiline—Insomnia—Rivastigmine—Alzheimer's disease	0.000215	0.00128	CcSEcCtD
Maprotiline—Dyspepsia—Memantine—Alzheimer's disease	0.000214	0.00127	CcSEcCtD
Maprotiline—HTR2A—nervous system—Alzheimer's disease	0.000214	0.00274	CbGeAlD
Maprotiline—Paraesthesia—Rivastigmine—Alzheimer's disease	0.000213	0.00127	CcSEcCtD
Maprotiline—Urticaria—Donepezil—Alzheimer's disease	0.000213	0.00126	CcSEcCtD
Maprotiline—Abdominal pain—Donepezil—Alzheimer's disease	0.000212	0.00125	CcSEcCtD
Maprotiline—Body temperature increased—Donepezil—Alzheimer's disease	0.000212	0.00125	CcSEcCtD
Maprotiline—Somnolence—Rivastigmine—Alzheimer's disease	0.000211	0.00125	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Memantine—Alzheimer's disease	0.00021	0.00124	CcSEcCtD
Maprotiline—Fatigue—Memantine—Alzheimer's disease	0.000209	0.00124	CcSEcCtD
Maprotiline—Dyspepsia—Rivastigmine—Alzheimer's disease	0.000209	0.00124	CcSEcCtD
Maprotiline—Constipation—Memantine—Alzheimer's disease	0.000208	0.00123	CcSEcCtD
Maprotiline—HTR2A—central nervous system—Alzheimer's disease	0.000206	0.00264	CbGeAlD
Maprotiline—Gastrointestinal disorder—Rivastigmine—Alzheimer's disease	0.000205	0.00122	CcSEcCtD
Maprotiline—Nausea—Galantamine—Alzheimer's disease	0.000205	0.00122	CcSEcCtD
Maprotiline—Fatigue—Rivastigmine—Alzheimer's disease	0.000205	0.00122	CcSEcCtD
Maprotiline—Constipation—Rivastigmine—Alzheimer's disease	0.000203	0.00121	CcSEcCtD
Maprotiline—Protriptyline—CYP2D6—Alzheimer's disease	0.000203	0.0397	CrCbGaD
Maprotiline—Imipramine—HTR6—Alzheimer's disease	0.000202	0.0394	CrCbGaD
Maprotiline—HTR2A—cerebellum—Alzheimer's disease	0.000201	0.00258	CbGeAlD
Maprotiline—Feeling abnormal—Memantine—Alzheimer's disease	0.0002	0.00119	CcSEcCtD
Maprotiline—Gastrointestinal pain—Memantine—Alzheimer's disease	0.000199	0.00118	CcSEcCtD
Maprotiline—Feeling abnormal—Rivastigmine—Alzheimer's disease	0.000196	0.00116	CcSEcCtD
Maprotiline—HRH1—brain—Alzheimer's disease	0.000196	0.00251	CbGeAlD
Maprotiline—CYP2D6—nervous system—Alzheimer's disease	0.000195	0.0025	CbGeAlD
Maprotiline—Gastrointestinal pain—Rivastigmine—Alzheimer's disease	0.000194	0.00115	CcSEcCtD
Maprotiline—Urticaria—Memantine—Alzheimer's disease	0.000193	0.00114	CcSEcCtD
Maprotiline—Abdominal pain—Memantine—Alzheimer's disease	0.000192	0.00114	CcSEcCtD
Maprotiline—Body temperature increased—Memantine—Alzheimer's disease	0.000192	0.00114	CcSEcCtD
Maprotiline—Asthenia—Donepezil—Alzheimer's disease	0.000192	0.00114	CcSEcCtD
Maprotiline—Pruritus—Donepezil—Alzheimer's disease	0.000189	0.00112	CcSEcCtD
Maprotiline—Urticaria—Rivastigmine—Alzheimer's disease	0.000189	0.00112	CcSEcCtD
Maprotiline—Abdominal pain—Rivastigmine—Alzheimer's disease	0.000188	0.00111	CcSEcCtD
Maprotiline—Body temperature increased—Rivastigmine—Alzheimer's disease	0.000188	0.00111	CcSEcCtD
Maprotiline—CYP2D6—central nervous system—Alzheimer's disease	0.000188	0.0024	CbGeAlD
Maprotiline—CYP2D6—cerebellum—Alzheimer's disease	0.000183	0.00235	CbGeAlD
Maprotiline—Diarrhoea—Donepezil—Alzheimer's disease	0.000183	0.00109	CcSEcCtD
Maprotiline—Dizziness—Donepezil—Alzheimer's disease	0.000177	0.00105	CcSEcCtD
Maprotiline—Asthenia—Memantine—Alzheimer's disease	0.000174	0.00103	CcSEcCtD
Maprotiline—Pruritus—Memantine—Alzheimer's disease	0.000172	0.00102	CcSEcCtD
Maprotiline—Asthenia—Rivastigmine—Alzheimer's disease	0.000171	0.00101	CcSEcCtD
Maprotiline—Vomiting—Donepezil—Alzheimer's disease	0.00017	0.00101	CcSEcCtD
Maprotiline—Rash—Donepezil—Alzheimer's disease	0.000169	0.001	CcSEcCtD
Maprotiline—Dermatitis—Donepezil—Alzheimer's disease	0.000169	0.001	CcSEcCtD
Maprotiline—Pruritus—Rivastigmine—Alzheimer's disease	0.000168	0.000997	CcSEcCtD
Maprotiline—Headache—Donepezil—Alzheimer's disease	0.000168	0.000994	CcSEcCtD
Maprotiline—Diarrhoea—Memantine—Alzheimer's disease	0.000166	0.000986	CcSEcCtD
Maprotiline—HTR2A—brain—Alzheimer's disease	0.000163	0.0021	CbGeAlD
Maprotiline—Diarrhoea—Rivastigmine—Alzheimer's disease	0.000163	0.000965	CcSEcCtD
Maprotiline—Dizziness—Memantine—Alzheimer's disease	0.000161	0.000953	CcSEcCtD
Maprotiline—Nausea—Donepezil—Alzheimer's disease	0.000159	0.000943	CcSEcCtD
Maprotiline—Dizziness—Rivastigmine—Alzheimer's disease	0.000157	0.000932	CcSEcCtD
Maprotiline—Vomiting—Memantine—Alzheimer's disease	0.000154	0.000916	CcSEcCtD
Maprotiline—Rash—Memantine—Alzheimer's disease	0.000153	0.000909	CcSEcCtD
Maprotiline—Dermatitis—Memantine—Alzheimer's disease	0.000153	0.000908	CcSEcCtD
Maprotiline—Headache—Memantine—Alzheimer's disease	0.000152	0.000903	CcSEcCtD
Maprotiline—Vomiting—Rivastigmine—Alzheimer's disease	0.000151	0.000896	CcSEcCtD
Maprotiline—Rash—Rivastigmine—Alzheimer's disease	0.00015	0.000889	CcSEcCtD
Maprotiline—Dermatitis—Rivastigmine—Alzheimer's disease	0.00015	0.000888	CcSEcCtD
Maprotiline—Headache—Rivastigmine—Alzheimer's disease	0.000149	0.000883	CcSEcCtD
Maprotiline—CYP2D6—brain—Alzheimer's disease	0.000149	0.00191	CbGeAlD
Maprotiline—Nausea—Memantine—Alzheimer's disease	0.000144	0.000856	CcSEcCtD
Maprotiline—Nausea—Rivastigmine—Alzheimer's disease	0.000141	0.000837	CcSEcCtD
Maprotiline—ABCB1—nervous system—Alzheimer's disease	0.00014	0.0018	CbGeAlD
Maprotiline—ABCB1—central nervous system—Alzheimer's disease	0.000135	0.00173	CbGeAlD
Maprotiline—ABCB1—cerebellum—Alzheimer's disease	0.000132	0.00169	CbGeAlD
Maprotiline—Atomoxetine—SLC6A4—Alzheimer's disease	0.000127	0.0248	CrCbGaD
Maprotiline—Nortriptyline—PTGS1—Alzheimer's disease	0.000114	0.0223	CrCbGaD
Maprotiline—Nortriptyline—SLC6A4—Alzheimer's disease	0.000111	0.0216	CrCbGaD
Maprotiline—ABCB1—brain—Alzheimer's disease	0.000107	0.00137	CbGeAlD
Maprotiline—Atomoxetine—HTR2A—Alzheimer's disease	9.74e-05	0.019	CrCbGaD
Maprotiline—Desipramine—SLC6A4—Alzheimer's disease	9.11e-05	0.0178	CrCbGaD
Maprotiline—Atomoxetine—CYP2D6—Alzheimer's disease	8.91e-05	0.0174	CrCbGaD
Maprotiline—Nortriptyline—HTR2A—Alzheimer's disease	8.51e-05	0.0166	CrCbGaD
Maprotiline—Nortriptyline—CYP2D6—Alzheimer's disease	7.78e-05	0.0152	CrCbGaD
Maprotiline—Imipramine—SLC6A4—Alzheimer's disease	7.73e-05	0.0151	CrCbGaD
Maprotiline—Desipramine—HTR2A—Alzheimer's disease	7e-05	0.0137	CrCbGaD
Maprotiline—Desipramine—CYP2D6—Alzheimer's disease	6.41e-05	0.0125	CrCbGaD
Maprotiline—Imipramine—HTR2A—Alzheimer's disease	5.94e-05	0.0116	CrCbGaD
Maprotiline—Imipramine—CYP2D6—Alzheimer's disease	5.43e-05	0.0106	CrCbGaD
Maprotiline—CYP2D6—Metabolism—PLCB1—Alzheimer's disease	5.15e-06	7.13e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—NGF—Alzheimer's disease	5.14e-06	7.12e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—NOS3—Alzheimer's disease	5.12e-06	7.09e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—ESR1—Alzheimer's disease	5.09e-06	7.05e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—CCR5—Alzheimer's disease	5.09e-06	7.05e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—CCR5—Alzheimer's disease	5.08e-06	7.04e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—CCR5—Alzheimer's disease	5.06e-06	7.01e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—HTR2A—Alzheimer's disease	5.06e-06	7.01e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—CCR5—Alzheimer's disease	5.05e-06	6.99e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—F2—Alzheimer's disease	5.03e-06	6.97e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—CCR5—Alzheimer's disease	5e-06	6.92e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—ABCA1—Alzheimer's disease	4.99e-06	6.92e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—PTGS1—Alzheimer's disease	4.97e-06	6.89e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—ENO1—Alzheimer's disease	4.97e-06	6.89e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—HTR2A—Alzheimer's disease	4.97e-06	6.89e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—HTR2A—Alzheimer's disease	4.96e-06	6.86e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—HTR2A—Alzheimer's disease	4.94e-06	6.84e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—NOTCH1—Alzheimer's disease	4.92e-06	6.82e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—NOS3—Alzheimer's disease	4.9e-06	6.79e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—HTR2A—Alzheimer's disease	4.89e-06	6.78e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—CYP2D6—Alzheimer's disease	4.88e-06	6.76e-05	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—PPARG—Alzheimer's disease	4.78e-06	6.63e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—CALM1—Alzheimer's disease	4.72e-06	6.54e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—LEP—Alzheimer's disease	4.71e-06	6.52e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—APOE—Alzheimer's disease	4.71e-06	6.52e-05	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—INS—Alzheimer's disease	4.69e-06	6.5e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—CAV1—Alzheimer's disease	4.66e-06	6.46e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—CALM1—Alzheimer's disease	4.65e-06	6.44e-05	CbGpPWpGaD
Maprotiline—HTR7—GPCR downstream signaling—AKT1—Alzheimer's disease	4.64e-06	6.43e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—CALM1—Alzheimer's disease	4.64e-06	6.42e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—LEP—Alzheimer's disease	4.63e-06	6.42e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—APOE—Alzheimer's disease	4.63e-06	6.42e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—BCHE—Alzheimer's disease	4.62e-06	6.41e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—CALM1—Alzheimer's disease	4.62e-06	6.4e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—LEP—Alzheimer's disease	4.62e-06	6.4e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—APOE—Alzheimer's disease	4.62e-06	6.4e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—GSK3B—Alzheimer's disease	4.62e-06	6.4e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—CALM1—Alzheimer's disease	4.61e-06	6.38e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—APOE—Alzheimer's disease	4.61e-06	6.38e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—LEP—Alzheimer's disease	4.61e-06	6.38e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—CASP3—Alzheimer's disease	4.6e-06	6.37e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—LEP—Alzheimer's disease	4.59e-06	6.36e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—APOE—Alzheimer's disease	4.59e-06	6.36e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—CAV1—Alzheimer's disease	4.59e-06	6.36e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—CREB1—Alzheimer's disease	4.58e-06	6.35e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—CAV1—Alzheimer's disease	4.58e-06	6.34e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling by GPCR—IL6—Alzheimer's disease	4.57e-06	6.33e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—PPARGC1A—Alzheimer's disease	4.57e-06	6.33e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—CAV1—Alzheimer's disease	4.56e-06	6.32e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—CALM1—Alzheimer's disease	4.56e-06	6.32e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—INS—Alzheimer's disease	4.56e-06	6.31e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—CAV1—Alzheimer's disease	4.55e-06	6.3e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—APOE—Alzheimer's disease	4.55e-06	6.3e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—LEP—Alzheimer's disease	4.55e-06	6.3e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—HMOX1—Alzheimer's disease	4.55e-06	6.3e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—CAV1—Alzheimer's disease	4.51e-06	6.24e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—ESR1—Alzheimer's disease	4.49e-06	6.23e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—CCL2—Alzheimer's disease	4.48e-06	6.21e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—F2—Alzheimer's disease	4.44e-06	6.15e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—ESR1—Alzheimer's disease	4.42e-06	6.13e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—ESR1—Alzheimer's disease	4.41e-06	6.11e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—IGF1—Alzheimer's disease	4.41e-06	6.11e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—ESR1—Alzheimer's disease	4.4e-06	6.09e-05	CbGpPWpGaD
Maprotiline—CHRM4—GPCR downstream signaling—AKT1—Alzheimer's disease	4.39e-06	6.08e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—ESR1—Alzheimer's disease	4.38e-06	6.07e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—F2—Alzheimer's disease	4.37e-06	6.05e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—PLCB1—Alzheimer's disease	4.36e-06	6.04e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—F2—Alzheimer's disease	4.36e-06	6.04e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—CASP3—Alzheimer's disease	4.35e-06	6.02e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—F2—Alzheimer's disease	4.34e-06	6.02e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—NOTCH1—Alzheimer's disease	4.34e-06	6.02e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—ESR1—Alzheimer's disease	4.34e-06	6.01e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—F2—Alzheimer's disease	4.33e-06	6e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling by GPCR—IL6—Alzheimer's disease	4.32e-06	5.98e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—PPARGC1A—Alzheimer's disease	4.3e-06	5.96e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—F2—Alzheimer's disease	4.29e-06	5.94e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—HMOX1—Alzheimer's disease	4.28e-06	5.93e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Alzheimer's disease	4.28e-06	5.93e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—NOTCH1—Alzheimer's disease	4.27e-06	5.92e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—NOTCH1—Alzheimer's disease	4.27e-06	5.91e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—NOTCH1—Alzheimer's disease	4.25e-06	5.89e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—NOTCH1—Alzheimer's disease	4.24e-06	5.87e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—ABCA1—Alzheimer's disease	4.23e-06	5.86e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—MAPK8—Alzheimer's disease	4.23e-06	5.86e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling by GPCR—AKT1—Alzheimer's disease	4.22e-06	5.84e-05	CbGpPWpGaD
Maprotiline—CHRM5—GPCR downstream signaling—AKT1—Alzheimer's disease	4.2e-06	5.82e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—NOTCH1—Alzheimer's disease	4.2e-06	5.81e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—CASP3—Alzheimer's disease	4.16e-06	5.76e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—LPL—Alzheimer's disease	4.16e-06	5.76e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling by GPCR—IL6—Alzheimer's disease	4.13e-06	5.73e-05	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—NOS3—Alzheimer's disease	4.11e-06	5.7e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—GSK3B—Alzheimer's disease	4.08e-06	5.65e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—CREB1—Alzheimer's disease	4.04e-06	5.6e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—INS—Alzheimer's disease	4.02e-06	5.57e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—GSK3B—Alzheimer's disease	4.01e-06	5.56e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—GSK3B—Alzheimer's disease	4e-06	5.54e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—NOS3—Alzheimer's disease	4e-06	5.54e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—MAPK8—Alzheimer's disease	3.99e-06	5.53e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—GSK3B—Alzheimer's disease	3.99e-06	5.53e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling by GPCR—AKT1—Alzheimer's disease	3.98e-06	5.52e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—CREB1—Alzheimer's disease	3.98e-06	5.51e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—GSK3B—Alzheimer's disease	3.98e-06	5.51e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—CREB1—Alzheimer's disease	3.97e-06	5.5e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—CREB1—Alzheimer's disease	3.96e-06	5.48e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—INS—Alzheimer's disease	3.96e-06	5.48e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—CCL2—Alzheimer's disease	3.96e-06	5.48e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—INS—Alzheimer's disease	3.95e-06	5.47e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—CREB1—Alzheimer's disease	3.95e-06	5.46e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—GSK3B—Alzheimer's disease	3.94e-06	5.46e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—INS—Alzheimer's disease	3.94e-06	5.45e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—INS—Alzheimer's disease	3.92e-06	5.43e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—LPL—Alzheimer's disease	3.92e-06	5.43e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—CREB1—Alzheimer's disease	3.91e-06	5.41e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—VEGFA—Alzheimer's disease	3.91e-06	5.41e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—CCL2—Alzheimer's disease	3.89e-06	5.39e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—IGF1—Alzheimer's disease	3.89e-06	5.39e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—INS—Alzheimer's disease	3.89e-06	5.38e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—CCL2—Alzheimer's disease	3.89e-06	5.38e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—CCL2—Alzheimer's disease	3.87e-06	5.36e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—CCL2—Alzheimer's disease	3.86e-06	5.35e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—IGF1—Alzheimer's disease	3.83e-06	5.3e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—MAPK8—Alzheimer's disease	3.83e-06	5.3e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—CCL2—Alzheimer's disease	3.82e-06	5.29e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—IGF1—Alzheimer's disease	3.82e-06	5.29e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling by GPCR—AKT1—Alzheimer's disease	3.81e-06	5.28e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—IGF1—Alzheimer's disease	3.81e-06	5.27e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—IGF1—Alzheimer's disease	3.79e-06	5.26e-05	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—PTGS2—Alzheimer's disease	3.76e-06	5.21e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—IGF1—Alzheimer's disease	3.76e-06	5.21e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—MTHFR—Alzheimer's disease	3.74e-06	5.18e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—VEGFA—Alzheimer's disease	3.69e-06	5.11e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—PPARGC1A—Alzheimer's disease	3.65e-06	5.05e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—HMOX1—Alzheimer's disease	3.63e-06	5.03e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—TGFB1—Alzheimer's disease	3.58e-06	4.96e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—VEGFA—Alzheimer's disease	3.53e-06	4.89e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—MTHFR—Alzheimer's disease	3.53e-06	4.89e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—NOS3—Alzheimer's disease	3.53e-06	4.88e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—CALM1—Alzheimer's disease	3.5e-06	4.84e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—APOE—Alzheimer's disease	3.49e-06	4.83e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—NOS3—Alzheimer's disease	3.47e-06	4.81e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—NOS3—Alzheimer's disease	3.46e-06	4.8e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—CAV1—Alzheimer's disease	3.45e-06	4.78e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—NOS3—Alzheimer's disease	3.45e-06	4.78e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—NOS3—Alzheimer's disease	3.44e-06	4.77e-05	CbGpPWpGaD
Maprotiline—HTR2C—GPCR downstream signaling—AKT1—Alzheimer's disease	3.42e-06	4.74e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—NOS3—Alzheimer's disease	3.41e-06	4.72e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—CASP3—Alzheimer's disease	3.39e-06	4.7e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—TGFB1—Alzheimer's disease	3.38e-06	4.69e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—IL6—Alzheimer's disease	3.37e-06	4.67e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—LPL—Alzheimer's disease	3.32e-06	4.6e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—CALM1—Alzheimer's disease	3.3e-06	4.56e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—APOE—Alzheimer's disease	3.28e-06	4.55e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—CAV1—Alzheimer's disease	3.25e-06	4.51e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—TGFB1—Alzheimer's disease	3.24e-06	4.49e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—MAPK8—Alzheimer's disease	3.12e-06	4.32e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—AKT1—Alzheimer's disease	3.11e-06	4.31e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—PPARG—Alzheimer's disease	3.04e-06	4.2e-05	CbGpPWpGaD
Maprotiline—DRD2—GPCR downstream signaling—AKT1—Alzheimer's disease	3.02e-06	4.19e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—CASP3—Alzheimer's disease	2.99e-06	4.15e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—MTHFR—Alzheimer's disease	2.99e-06	4.14e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—INS—Alzheimer's disease	2.98e-06	4.12e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—IL6—Alzheimer's disease	2.97e-06	4.12e-05	CbGpPWpGaD
Maprotiline—HTR2A—GPCR downstream signaling—AKT1—Alzheimer's disease	2.97e-06	4.12e-05	CbGpPWpGaD
Maprotiline—HRH1—GPCR downstream signaling—AKT1—Alzheimer's disease	2.97e-06	4.11e-05	CbGpPWpGaD
Maprotiline—CHRM1—GPCR downstream signaling—AKT1—Alzheimer's disease	2.96e-06	4.1e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—TP53—Alzheimer's disease	2.95e-06	4.09e-05	CbGpPWpGaD
Maprotiline—CHRM3—GPCR downstream signaling—AKT1—Alzheimer's disease	2.95e-06	4.08e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—CASP3—Alzheimer's disease	2.95e-06	4.08e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—CASP3—Alzheimer's disease	2.94e-06	4.07e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—CASP3—Alzheimer's disease	2.93e-06	4.06e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—IL6—Alzheimer's disease	2.93e-06	4.05e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—CASP3—Alzheimer's disease	2.92e-06	4.05e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—IL6—Alzheimer's disease	2.92e-06	4.05e-05	CbGpPWpGaD
Maprotiline—CHRM2—GPCR downstream signaling—AKT1—Alzheimer's disease	2.92e-06	4.04e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—IL6—Alzheimer's disease	2.91e-06	4.03e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—IL6—Alzheimer's disease	2.9e-06	4.02e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—CASP3—Alzheimer's disease	2.89e-06	4.01e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—VEGFA—Alzheimer's disease	2.88e-06	3.99e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—IL6—Alzheimer's disease	2.87e-06	3.98e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—PPARG—Alzheimer's disease	2.86e-06	3.96e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—INS—Alzheimer's disease	2.81e-06	3.89e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—CALM1—Alzheimer's disease	2.79e-06	3.87e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—TP53—Alzheimer's disease	2.79e-06	3.86e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—APOE—Alzheimer's disease	2.78e-06	3.85e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—CAV1—Alzheimer's disease	2.76e-06	3.82e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—MAPK8—Alzheimer's disease	2.75e-06	3.81e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—AKT1—Alzheimer's disease	2.74e-06	3.8e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—MAPK8—Alzheimer's disease	2.71e-06	3.75e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—MAPK8—Alzheimer's disease	2.7e-06	3.74e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—IL6—Alzheimer's disease	2.7e-06	3.74e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—AKT1—Alzheimer's disease	2.7e-06	3.74e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—AKT1—Alzheimer's disease	2.69e-06	3.73e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—MAPK8—Alzheimer's disease	2.69e-06	3.73e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—AKT1—Alzheimer's disease	2.69e-06	3.72e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—MAPK8—Alzheimer's disease	2.68e-06	3.72e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—AKT1—Alzheimer's disease	2.68e-06	3.71e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—TP53—Alzheimer's disease	2.67e-06	3.7e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—MAPK8—Alzheimer's disease	2.66e-06	3.68e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—AKT1—Alzheimer's disease	2.65e-06	3.67e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—TGFB1—Alzheimer's disease	2.64e-06	3.66e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—NOS3—Alzheimer's disease	2.61e-06	3.62e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—IL6—Alzheimer's disease	2.55e-06	3.53e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—VEGFA—Alzheimer's disease	2.54e-06	3.52e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—VEGFA—Alzheimer's disease	2.5e-06	3.46e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—VEGFA—Alzheimer's disease	2.49e-06	3.46e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—AKT1—Alzheimer's disease	2.49e-06	3.45e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—VEGFA—Alzheimer's disease	2.49e-06	3.44e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—VEGFA—Alzheimer's disease	2.48e-06	3.43e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—NOS3—Alzheimer's disease	2.46e-06	3.41e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—VEGFA—Alzheimer's disease	2.45e-06	3.4e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—IL6—Alzheimer's disease	2.44e-06	3.38e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—PPARG—Alzheimer's disease	2.42e-06	3.36e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—PTGS2—Alzheimer's disease	2.39e-06	3.31e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—INS—Alzheimer's disease	2.38e-06	3.29e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—AKT1—Alzheimer's disease	2.35e-06	3.26e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—TGFB1—Alzheimer's disease	2.33e-06	3.23e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—TGFB1—Alzheimer's disease	2.29e-06	3.18e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—TGFB1—Alzheimer's disease	2.29e-06	3.17e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—TGFB1—Alzheimer's disease	2.28e-06	3.16e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—TGFB1—Alzheimer's disease	2.28e-06	3.15e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—AKT1—Alzheimer's disease	2.25e-06	3.12e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—TGFB1—Alzheimer's disease	2.25e-06	3.12e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—PTGS2—Alzheimer's disease	2.25e-06	3.12e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—TP53—Alzheimer's disease	2.18e-06	3.01e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—NOS3—Alzheimer's disease	2.08e-06	2.89e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—IL6—Alzheimer's disease	1.99e-06	2.76e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—TP53—Alzheimer's disease	1.92e-06	2.66e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—PTGS2—Alzheimer's disease	1.91e-06	2.64e-05	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—AKT1—Alzheimer's disease	1.89e-06	2.62e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—TP53—Alzheimer's disease	1.89e-06	2.62e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—TP53—Alzheimer's disease	1.88e-06	2.61e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—TP53—Alzheimer's disease	1.88e-06	2.6e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—TP53—Alzheimer's disease	1.87e-06	2.59e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—TP53—Alzheimer's disease	1.85e-06	2.57e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—AKT1—Alzheimer's disease	1.84e-06	2.54e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—IL6—Alzheimer's disease	1.76e-06	2.43e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—IL6—Alzheimer's disease	1.73e-06	2.39e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—IL6—Alzheimer's disease	1.73e-06	2.39e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—IL6—Alzheimer's disease	1.72e-06	2.38e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—IL6—Alzheimer's disease	1.71e-06	2.37e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—IL6—Alzheimer's disease	1.7e-06	2.35e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—AKT1—Alzheimer's disease	1.62e-06	2.25e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—AKT1—Alzheimer's disease	1.6e-06	2.21e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—AKT1—Alzheimer's disease	1.59e-06	2.2e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—AKT1—Alzheimer's disease	1.59e-06	2.2e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—AKT1—Alzheimer's disease	1.58e-06	2.19e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—AKT1—Alzheimer's disease	1.57e-06	2.17e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—AKT1—Alzheimer's disease	1.2e-06	1.66e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—AKT1—Alzheimer's disease	1.13e-06	1.57e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—AKT1—Alzheimer's disease	9.58e-07	1.33e-05	CbGpPWpGaD
